However, a subsequent study showed that activation of the TNF pathway in cultured podocytes exposed to serum from FSGS patients occurred in 21% of cases, irrespective of circulating TNF-α levels (81). The gene discussed is TNF; the disease is focal segmental glomerulosclerosis.